GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valeo Pharma Inc (TSX:VPH) » Definitions » Goodwill-to-Asset

Valeo Pharma (TSX:VPH) Goodwill-to-Asset : 0.00 (As of Jul. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Valeo Pharma Goodwill-to-Asset?

Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets. Valeo Pharma's Goodwill for the quarter that ended in Jul. 2024 was C$0.00 Mil. Valeo Pharma's Total Assets for the quarter that ended in Jul. 2024 was C$32.20 Mil. Therefore, Valeo Pharma's Goodwill to Asset Ratio for the quarter that ended in Jul. 2024 was 0.00.


Valeo Pharma Goodwill-to-Asset Historical Data

The historical data trend for Valeo Pharma's Goodwill-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valeo Pharma Goodwill-to-Asset Chart

Valeo Pharma Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Goodwill-to-Asset
Get a 7-Day Free Trial - - - - -

Valeo Pharma Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Goodwill-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Valeo Pharma's Goodwill-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Valeo Pharma's Goodwill-to-Asset, along with its competitors' market caps and Goodwill-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Valeo Pharma's Goodwill-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Valeo Pharma's Goodwill-to-Asset distribution charts can be found below:

* The bar in red indicates where Valeo Pharma's Goodwill-to-Asset falls into.



Valeo Pharma Goodwill-to-Asset Calculation

Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets.

It is calculated by dividing goodwill by total assets.

Valeo Pharma's Goodwill to Asset Ratio for the fiscal year that ended in Oct. 2023 is calculated as

Goodwill to Asset (A: Oct. 2023 )=Goodwill/Total Assets
=0/41.207
=0.00

Valeo Pharma's Goodwill to Asset Ratio for the quarter that ended in Jul. 2024 is calculated as

Goodwill to Asset (Q: Jul. 2024 )=Goodwill/Total Assets
=0/32.195
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Valeo Pharma  (TSX:VPH) Goodwill-to-Asset Explanation

If the goodwill-to-asset ratio increases, it can mean that the company is recording a proportionately higher amount of goodwill, assuming total assets are remaining constant. It is generally good to see a company increasing its assets regularly; however, if these increases are coming from intangible assets, such as goodwill, the increases may not be as good.

Increases in the goodwill-to-asset ratio might suggest that a company has been aggressively acquiring other firms or has seen its tangible assets decrease in value. When a large portion of total assets are attributable to intangible assets (such as goodwill), the company may be at risk of having that portion of its asset base wiped out quickly if it must record any goodwill impairments. Decreases in the goodwill-to-assets ratio suggest that the company has either written down some goodwill or increased its tangible assets.

Asset needs vary from industry to industry. This is why comparing goodwill-to-assets ratios is generally most meaningful among companies within the same industry. By comparing a company's goodwill to assets ratio to those of other companies within the same industry, investors can get a feel for how a company is managing its goodwill.


Valeo Pharma Goodwill-to-Asset Related Terms

Thank you for viewing the detailed overview of Valeo Pharma's Goodwill-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Valeo Pharma Business Description

Traded in Other Exchanges
N/A
Address
16667, Hymus Boulevard, Kirkland, QC, CAN, H9H 4R9
Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and hospital specialty products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.
Executives
Luc Mainville Senior Officer
100079 Canada Inc. 10% Security Holder
Richard J. Mackay Director, Director or Senior Officer of 10% Security Holder
Steve Saviuk Director, Director or Senior Officer of 10% Security Holder, Senior Officer
Jeffrey Michael Skinner Senior Officer
Frederic Fasano Director
Guy Paul Allard Director or Senior Officer of 10% Security Holder, Senior Officer
Marc François Léger Senior Officer

Valeo Pharma Headlines

No Headlines